Bax在14-3-3γ对抗脂多糖诱导的心肌细胞损伤中的作用

被引:1
作者
刘丹 [1 ]
尹东 [2 ]
孙惦 [1 ]
许旻 [1 ]
何明 [1 ]
机构
[1] 南昌大学医学院
[2] 江西省分子医学重点实验室
关键词
脂多糖类; 肌细胞; 心脏; 创伤和损伤; 基因,肿瘤抑制; bcl-2相关X蛋白质; 14-3-3蛋白质类;
D O I
暂无
中图分类号
R363 [病理生理学];
学科分类号
100103 [病原生物学];
摘要
目的:探讨14-3-3γ对脂多糖(LPS)所致心肌损伤的作用与抑制Bax向线粒体移位的关系。方法:采用原代SD乳鼠心肌细胞,随机分为4组:对照组;LPS组,LPS10mg/L加至培养基中6h;pFLAG+LPS组,空载质粒pFLAG转染至心肌细胞,24h后处理同LPS组;pFLAG-14-3-3γ+LPS组,重组质粒pFLAG-14-3-3γ转染至心肌细胞,24h后处理同LPS组。四唑盐(MTT)比色法检测各组细胞存活率,全自动生化分析仪检测乳酸脱氢酶(LDH)、肌酸磷酸酶(CPK)值,流式细胞仪检测细胞凋亡率,Western blotting检测细胞14-3-3γ蛋白水平、细胞浆及线粒体的Bax蛋白水平。结果:LPS致心肌细胞损伤,与对照组相比,LPS处理使细胞存活率明显下降(P<0.01),LDH、CPK值明显升高(P<0.01),细胞凋亡率增加(P<0.01),促使Bax蛋白从胞浆向线粒体移位,转染重组质粒pFLAG-14-3-3γ使14-3-3γ在心肌细胞内高表达后可明显逆转LPS所致的损伤,上述各指标均有所改善,并抑制Bax蛋白向线粒体的移位。结论:14-3-3γ对抗LPS所致心肌细胞损伤与抑制Bax从胞浆向线粒体移位有关。
引用
收藏
页码:1222 / 1225
页数:4
相关论文
共 5 条
[1]
Kinetics of IL-6 and TNF-α changes in a canine model of sepsis induced by endotoxin [J].
Song, Ruhui ;
Kim, Junhwan ;
Yu, Dohyeon ;
Park, Chul ;
Park, Jinho .
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2012, 146 (02) :143-149
[2]
14-3-3 proteins – A family of universal scaffolds and regulators.[J].Tomas Obsil.Seminars in Cell and Developmental Biology.2011, 7
[3]
PRETREATMENT WITH BERBERINE AND YOHIMBINE PROTECTS AGAINST LPS-INDUCED MYOCARDIAL DYSFUNCTION VIA INHIBITION OF CARDIAC I-κBα PHOSPHORYLATION AND APOPTOSIS IN MICE [J].
Wang, Yi-yang ;
Li, Hong-mei ;
Wang, Hua-dong ;
Peng, Xue-mei ;
Wang, Yan-ping ;
Lu, Da-xiang ;
Qi, Ren-bin ;
Hu, Chao-feng ;
Jiang, Jian-wei .
SHOCK, 2011, 35 (03) :322-328
[4]
Pim-3 protects against cardiomyocyte apoptosis in anoxia/reoxygenation injury via p38-mediated signal pathway [J].
Liu, Dan ;
He, Ming ;
Yi, Bo ;
Guo, Wu-hua ;
Que, Ai-ling ;
Zhang, Ji-xiang .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2009, 41 (11) :2315-2322
[5]
Upregulation of 14-3-3 isoforms in acute rat myocardial injuries induced by burn and lipopolysaccharide [J].
He, M ;
Zhang, JX ;
Shao, LJ ;
Huang, QR ;
Chen, J ;
Chen, HP ;
Chen, XY ;
Liu, D ;
Luo, ZJ .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2006, 33 (04) :374-380